ReviewAdvances and technical standards in neurosurgery2026
Management of Anterior Third Ventricular Tumors: A Comprehensive Review and Clinical Experience.
Review in Advances and technical standards in neurosurgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anterior third ventricular tumors, encompassing colloid cysts, gliomas, craniopharyngiomas, and neurocytomas, are rare intracranial neoplasms that present significant diagnostic and therapeutic challenges due to their deep-seated location and proximity to critical neurovascular structures. This chapter synthesizes current literature on their natural history, diagnostic approaches, and management strategies, integrating our clinical experience with 193 cases treated between 1995 and 2023. We explore observation, microsurgical resection, endoscopic surgery, and stereotactic radiosurgery (SRS), providing an in-depth analysis of surgical techniques, their nuances, benefits, and risks. The commonest diagnosis in our series was colloid cyst (72.5%). We achieved a 81.5% complete resection rate with 12% complications overall. Major studies are reviewed to compare outcomes, and a management algorithm is proposed to guide individualized treatment, emphasizing tumor control and quality of life (QOL) preservation. Additionally, emerging molecular and genetic insights into these tumors, pediatric-specific considerations, quality-of-life outcomes, long-term follow-up strategies, and novel surgical or radiological techniques, reflecting the latest evidence-based advancements in the field, are discussed.
Indexed as
Identifiers
42393446What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.